{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:40:24Z","timestamp":1790322024402,"version":"4.1.0"},"reference-count":62,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Stilbenoids are bioactive polyphenols, and resveratrol (trans-3,5,40-trihydroxystilbene) is a representative stilbenoid that reportedly exerts cardioprotective actions. As resveratrol exhibits low oral bioavailability, we turned our attention to other stilbenoid compounds with a history of medicinal use and\/or improved bioavailability. We determined the effects of gnetol (trans-3,5,20,60-tetrahydroxystilbene) and pterostilbene (trans-3,5-dimethoxy-40-hydroxystilbene) on cardiac hypertrophy. In vitro, gnetol and pterostilbene prevented endothelin-1-induced indicators of cardiomyocyte hypertrophy including cell enlargement and protein synthesis. Gnetol and pterostilbene stimulated AMP-activated protein kinase (AMPK), and inhibition of AMPK, using compound C or shRNA knockdown,abolished these anti-hypertrophiceffects. In contrast,resveratrol, gnetol, nor pterostilbene reduced blood pressure or hypertrophy in the spontaneously hypertensive heart failure (SHHF) rat. In fact, AMPK levels were similar between Sprague-Dawley and SHHF rats whether treated by stilbenoids or not. These data suggest that the anti-hypertrophic actions of resveratrol (and other stilbenoids?) do not extend to the SHHF rat, which models heart failure superimposed on hypertension. Notably, SHHF rat hearts exhibited prolonged isovolumic  relaxationtime(an indicator of diastolicdys function),and this was improved by stilbenoid treatment.In conclusion, stilbenoid-based treatment as a viable strategy to prevent pathological cardiac hypertrophy,a major risk factor for heart failure,may be context-dependent and requires furtherstudy.<\/jats:p>","DOI":"10.3390\/molecules22020204","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T10:53:53Z","timestamp":1485946433000},"page":"204","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Disparate Effects of Stilbenoid Polyphenols on Hypertrophic Cardiomyocytes In Vitro vs. in the Spontaneously Hypertensive Heart Failure Rat"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7018-1001","authenticated-orcid":false,"given":"Bolanle","family":"Akinwumi","sequence":"first","affiliation":[{"name":"College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB R3E 0T5, Canada"},{"name":"Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Research Centre, 351 Tach\u00e9 Avenue, Winnipeg, MB R2H 2A6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pema","family":"Raj","sequence":"additional","affiliation":[{"name":"Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Research Centre, 351 Tach\u00e9 Avenue, Winnipeg, MB R2H 2A6, Canada"},{"name":"Department of Physiology and Pathophysiology, Max Rady College of Medicine, University of Manitoba, 753 McDermot Avenue, Winnipeg, MB R3E 0T6, Canada"},{"name":"Agriculture and Agri-Food Canada, St. Boniface Hospital Research Centre, 351 Tach\u00e9 Avenue, Winnipeg, MB R2H 2A6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB R3E 0T5, Canada"},{"name":"Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Research Centre, 351 Tach\u00e9 Avenue, Winnipeg, MB R2H 2A6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Acosta","sequence":"additional","affiliation":[{"name":"Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Research Centre, 351 Tach\u00e9 Avenue, Winnipeg, MB R2H 2A6, Canada"},{"name":"Department of Pharmacology and Therapeutics, Max Rady College of Medicine, University of Manitoba, 753 McDermot Avenue, Winnipeg, MB R3E 0T6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yu","sequence":"additional","affiliation":[{"name":"Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Research Centre, 351 Tach\u00e9 Avenue, Winnipeg, MB R2H 2A6, Canada"},{"name":"Agriculture and Agri-Food Canada, St. Boniface Hospital Research Centre, 351 Tach\u00e9 Avenue, Winnipeg, MB R2H 2A6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Thomas","sequence":"additional","affiliation":[{"name":"Sami Labs Ltd., Peenya Industrial Area, Bangalore 560058, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9470-4110","authenticated-orcid":false,"given":"Kalyanam","family":"Nagabhushanam","sequence":"additional","affiliation":[{"name":"Sabinsa Corporation, 20 Lake Drive, East Windsor, NJ 08520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Majeed","sequence":"additional","affiliation":[{"name":"Sami Labs Ltd., Peenya Industrial Area, Bangalore 560058, India"},{"name":"Sabinsa Corporation, 20 Lake Drive, East Windsor, NJ 08520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7050-1471","authenticated-orcid":false,"given":"Neal","family":"Davies","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB R3E 0T5, Canada"},{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 2-35, Medical Sciences Building, Edmonton, AL T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Netticadan","sequence":"additional","affiliation":[{"name":"Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Research Centre, 351 Tach\u00e9 Avenue, Winnipeg, MB R2H 2A6, Canada"},{"name":"Department of Physiology and Pathophysiology, Max Rady College of Medicine, University of Manitoba, 753 McDermot Avenue, Winnipeg, MB R3E 0T6, Canada"},{"name":"Agriculture and Agri-Food Canada, St. Boniface Hospital Research Centre, 351 Tach\u00e9 Avenue, Winnipeg, MB R2H 2A6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6570-6678","authenticated-orcid":false,"given":"Hope","family":"Anderson","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB R3E 0T5, Canada"},{"name":"Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Research Centre, 351 Tach\u00e9 Avenue, Winnipeg, MB R2H 2A6, Canada"},{"name":"Department of Pharmacology and Therapeutics, Max Rady College of Medicine, University of Manitoba, 753 McDermot Avenue, Winnipeg, MB R3E 0T6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"key":"ref_1","unstructured":"Parker, P., Patterson, J., and Johnson, J. (2005). Pharmacotherapy. A Pathophysiologic Approach: Heart Failure, The McGraw-Hill Companies, Inc.. [6th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study","volume":"322","author":"Levy","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The epidemiology of heart failure: The Framingham study","volume":"22","author":"Ho","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","first-page":"H8","article-title":"Does load-induced ventricular hypertrophy progress to systolic heart failure?","volume":"289","author":"Berenji","year":"2005","journal-title":"Am. J. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: A new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbadis.2014.10.016","article-title":"Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases","volume":"1852","author":"Zordoky","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.20463\/jenb.2016.03.20.1.2","article-title":"Age impaired endothelium-dependent vasodilation is improved by resveratrol in rat mesenteric arteries","volume":"20","author":"Gocmez","year":"2016","journal-title":"J. Exerc. Nutr. Biochem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2174\/1568026616666160204121431","article-title":"Resveratrol as a potential therapeutic candidate for the treatment and management of Alzheimer\u2018s disease","volume":"16","author":"Braidy","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: The in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ajh.2010.161","article-title":"Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat","volume":"23","author":"Behbahani","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ajh.2009.228","article-title":"Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure","volume":"23","author":"Thandapilly","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1208\/s12249-014-0211-y","article-title":"Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design","volume":"16","author":"Hao","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00280-010-1525-4","article-title":"Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats","volume":"68","author":"Kapetanovic","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.jss.2011.09.054","article-title":"Pterostilbene and cancer: Current review","volume":"173","author":"McCormack","year":"2012","journal-title":"J. Surg. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1021\/jf0009910","article-title":"Stilbene content of mature Vitis vinifera berries in response to UV-C elicitation","volume":"48","author":"Adrian","year":"2000","journal-title":"J. Agric. Food Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1021\/jf040095e","article-title":"Resveratrol, pterostilbene, and piceatannol in Vaccinium berries","volume":"52","author":"Rimando","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-8741(99)00044-6","article-title":"Occurrence of resveratrol and pterostilbene in age-old darakchasava, an Ayurvedic medicine from India","volume":"68","author":"Paul","year":"1999","journal-title":"J. Ethnopharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ptr.2277","article-title":"Pharmacometrics of pterostilbene: Preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity","volume":"22","author":"Remsberg","year":"2008","journal-title":"Phytother. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/np020532o","article-title":"Phenolic constituents of Gnetum klossii","volume":"66","author":"Ali","year":"2003","journal-title":"J. Nat. Prod."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0031-9422(00)00151-5","article-title":"Stilbene dimers from the lianas of Gnetum hainanense","volume":"54","author":"Huang","year":"2000","journal-title":"Phytochemistry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0006-291X(03)01284-1","article-title":"Effects of hydroxystilbene derivatives on tyrosinase activity","volume":"307","author":"Ohguchi","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0367-326X(01)00370-7","article-title":"Constituents of Gnetum montanum","volume":"73","author":"Xiang","year":"2002","journal-title":"Fitoterapia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/jf803077p","article-title":"Stilbenoids isolated from the seeds of melinjo (Gnetum gnemon L.) and their biological activity","volume":"57","author":"Kato","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/cam4.520","article-title":"Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo","volume":"4","author":"Narayanan","year":"2015","journal-title":"Cancer Med"},{"key":"ref_25","first-page":"H2138","article-title":"Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol","volume":"292","author":"Juric","year":"2007","journal-title":"Am. J. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3945\/jn.109.115006","article-title":"Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats","volume":"140","author":"Wojciechowski","year":"2010","journal-title":"J. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.787440","article-title":"Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1","volume":"119","author":"Dolinsky","year":"2009","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00210-003-0849-6","article-title":"Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy","volume":"369","author":"Cheng","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"24194","DOI":"10.1074\/jbc.M802869200","article-title":"Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and akt","volume":"283","author":"Chan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Planavila, A., Iglesias, R., Giralt, M., and Villarroya, F. (2010). Sirt1 acts in association with ppar{alpha} to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc. Res.","DOI":"10.1093\/cvr\/cvq376"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejphar.2011.06.042","article-title":"Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating no-AMPK pathway","volume":"668","author":"Thandapilly","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_32","first-page":"H2557","article-title":"Role of AMP-activated protein kinase in healthy and diseased hearts","volume":"291","author":"Dolinsky","year":"2006","journal-title":"Am. J. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"32771","DOI":"10.1074\/jbc.M403528200","article-title":"Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte","volume":"279","author":"Chan","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/aps.2010.73","article-title":"Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the Foxo1\/Murf1 signaling pathway in vitro","volume":"31","author":"Chen","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"32562","DOI":"10.1074\/jbc.M801904200","article-title":"Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase","volume":"283","author":"Stuck","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/jcb.21197","article-title":"Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy","volume":"100","author":"Li","year":"2007","journal-title":"J. Cell. Biochem"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tibs.2005.11.009","article-title":"Chutes and ladders: The search for protein kinases that act on AMPK","volume":"31","author":"Witters","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/cvr\/cvr034","article-title":"Ampk activation, a preventive therapeutic target in the transition from cardiac injury to heart failure","volume":"90","author":"Beauloye","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_39","first-page":"194","article-title":"Contemporary treatment of hypertrophic cardiomyopathy","volume":"36","author":"Marian","year":"2009","journal-title":"Tex. Heart Inst. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/clc.4960160110","article-title":"Asymmetrical septal hypertrophy in patients with hypertension: A type of hypertensive left ventricular hypertrophy or hypertrophic cardiomyopathy combined with hypertension?","volume":"16","author":"Shimizu","year":"1993","journal-title":"Clin. Cardiol."},{"key":"ref_41","first-page":"H1775","article-title":"Structural, functional, and molecular characterization of the SHHF model of heart failure","volume":"283","author":"Heyen","year":"2002","journal-title":"Am.  J. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.HYP.28.4.609","article-title":"Myocyte remodeling during the progression to failure in rats with hypertension","volume":"28","author":"Gerdes","year":"1996","journal-title":"Hypertension"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.taap.2013.08.012","article-title":"Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats","volume":"273","author":"Sharkey","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2337\/db11-1132","article-title":"Metformin prevents the development of chronic heart failure in the SHHF rat model","volume":"61","author":"Cittadini","year":"2012","journal-title":"Diabetes"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/ptr.5363","article-title":"Preclinical pharmacokinetics and pharmacodynamics and content analysis of gnetol in foodstuffs","volume":"29","author":"Remsberg","year":"2015","journal-title":"Phytother. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/FJC.0000000000000134","article-title":"Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes","volume":"64","author":"Lu","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.RES.0000201960.04223.3c","article-title":"Rho kinases in cardiovascular physiology and pathophysiology","volume":"98","author":"Loirand","year":"2006","journal-title":"Circ. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11010-013-1832-2","article-title":"Prevention of rhoa activation and cofilin-mediated actin polymerization mediates the antihypertrophic effect of adenosine receptor agonists in angiotensin II- and endothelin-1-treated cardiomyocytes","volume":"385","author":"Zeidan","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.RES.0000216039.75913.9e","article-title":"The Rac and Rho hall of fame: A decade of hypertrophic signaling hits","volume":"98","author":"Brown","year":"2006","journal-title":"Circ. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1440-1681.2010.05461.x","article-title":"Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats","volume":"38","author":"Zhang","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/HYPERTENSIONAHA.110.154732","article-title":"Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat","volume":"56","author":"Dolinsky","year":"2010","journal-title":"Hypertension"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.yjmcc.2009.09.012","article-title":"Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a rhoa-rock-dependent pathway","volume":"47","author":"Hunter","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_53","first-page":"H1131","article-title":"Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol","volume":"288","author":"Olson","year":"2005","journal-title":"Am. J. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11683","DOI":"10.1021\/jf802357g","article-title":"Preventive effects of nutritional doses of polyphenolic molecules on cardiac fibrosis associated with metabolic syndrome: Involvement of osteopontin and oxidative stress","volume":"56","author":"Sutra","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/hr.2009.47","article-title":"Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis","volume":"32","author":"Inanaga","year":"2009","journal-title":"Hypertens. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/138920111794480552","article-title":"Resveratrol improves cardiovascular function in doca-salt hypertensive rats","volume":"12","author":"Chan","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/hr.2013.55","article-title":"Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats","volume":"36","author":"Thandapilly","year":"2013","journal-title":"Hypertens. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1021\/op049889k","article-title":"A scaleable synthesis of fiduxosin","volume":"8","author":"Haight","year":"2004","journal-title":"Org. Proc. Res. Dev."},{"key":"ref_59","unstructured":"Majeed, M., Thomas, S.M., Nagabhushanam, K., Balakrishnan, S.K., and Prakash, S. (2007). Process for the Synthesis of Biologically Active Oxygenated Compounds by Dealkylation of the Corresponding Alkylethers. (7253324 B1), Patent U.S."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1016\/S0021-9258(18)83372-5","article-title":"Tissue-specific determinants of human atrial natriuretic factor gene expression in cardiac tissue","volume":"264","author":"Wu","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.1074\/jbc.M800035200","article-title":"Suppression of cardiac myocyte hypertrophy by conjugated linoleic acid: Role of peroxisome proliferator-activated receptors alpha and gamma","volume":"283","author":"Alibin","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/cvr\/cvq401","article-title":"Suppression of endothelin-1-induced cardiac myocyte hypertrophy by ppar agonists: Role of diacylglycerol kinase zeta","volume":"90","author":"Huang","year":"2011","journal-title":"Cardiovasc. Res."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/2\/204\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:27:20Z","timestamp":1760207240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/2\/204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2]]}},"alternative-id":["molecules22020204"],"URL":"https:\/\/doi.org\/10.3390\/molecules22020204","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,1]]}}}